FAM32A | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
natural killer cell	23 studies	20% ± 4%	Explore
non-classical monocyte	14 studies	34% ± 17%	Explore
CD8-positive, alpha-beta T cell	12 studies	22% ± 7%	Explore
classical monocyte	11 studies	26% ± 11%	Explore
B cell	11 studies	22% ± 8%	Explore
endothelial cell	11 studies	30% ± 12%	Explore
fibroblast	10 studies	25% ± 8%	Explore
CD16-negative, CD56-bright natural killer cell, human	9 studies	22% ± 4%	Explore
CD16-positive, CD56-dim natural killer cell, human	9 studies	23% ± 4%	Explore
smooth muscle cell	9 studies	21% ± 6%	Explore
regulatory T cell	9 studies	20% ± 4%	Explore
gamma-delta T cell	9 studies	22% ± 12%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	8 studies	22% ± 6%	Explore
epithelial cell	8 studies	34% ± 20%	Explore
pericyte	8 studies	25% ± 8%	Explore
naive B cell	7 studies	19% ± 3%	Explore
myofibroblast cell	7 studies	22% ± 2%	Explore
CD4-positive, alpha-beta T cell	6 studies	24% ± 6%	Explore
mature NK T cell	6 studies	19% ± 3%	Explore
connective tissue cell	6 studies	25% ± 8%	Explore
monocyte	6 studies	20% ± 5%	Explore
effector CD8-positive, alpha-beta T cell	5 studies	21% ± 3%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	5 studies	20% ± 3%	Explore
effector memory CD8-positive, alpha-beta T cell	5 studies	21% ± 5%	Explore
macrophage	5 studies	25% ± 7%	Explore
T cell	5 studies	18% ± 3%	Explore
endothelial cell of lymphatic vessel	5 studies	25% ± 8%	Explore
CD8-positive, alpha-beta memory T cell	5 studies	22% ± 9%	Explore
plasmacytoid dendritic cell	5 studies	24% ± 7%	Explore
conventional dendritic cell	4 studies	38% ± 18%	Explore
progenitor cell	4 studies	19% ± 2%	Explore
innate lymphoid cell	4 studies	19% ± 1%	Explore
basal cell	4 studies	33% ± 16%	Explore
neuron	4 studies	43% ± 19%	Explore
effector CD4-positive, alpha-beta T cell	4 studies	21% ± 2%	Explore
enteroendocrine cell	4 studies	25% ± 13%	Explore
goblet cell	4 studies	23% ± 9%	Explore
CD4-positive, alpha-beta memory T cell	4 studies	19% ± 3%	Explore
memory B cell	4 studies	17% ± 2%	Explore
mucosal invariant T cell	4 studies	18% ± 3%	Explore
squamous epithelial cell	3 studies	34% ± 21%	Explore
pancreatic A cell	3 studies	23% ± 4%	Explore
exhausted T cell	3 studies	26% ± 9%	Explore
hematopoietic precursor cell	3 studies	29% ± 9%	Explore
endothelial cell of artery	3 studies	19% ± 1%	Explore
mesothelial cell	3 studies	30% ± 17%	Explore
neural crest cell	3 studies	21% ± 3%	Explore
vein endothelial cell	3 studies	22% ± 7%	Explore
precursor B cell	3 studies	27% ± 5%	Explore
capillary endothelial cell	3 studies	23% ± 7%	Explore
immature B cell	3 studies	25% ± 8%	Explore
type I pneumocyte	3 studies	23% ± 3%	Explore
ciliated cell	3 studies	38% ± 2%	Explore
erythroblast	3 studies	26% ± 13%	Explore
abnormal cell	3 studies	26% ± 5%	Explore
endothelial cell of vascular tree	3 studies	18% ± 0%	Explore
glutamatergic neuron	3 studies	26% ± 7%	Explore
dendritic cell	3 studies	45% ± 19%	Explore
pancreatic ductal cell	3 studies	42% ± 14%	Explore
double negative thymocyte	3 studies	28% ± 11%	Explore
T follicular helper cell	3 studies	16% ± 1%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
peripheral blood	13 studies	22% ± 8%	Explore
intestine	6 studies	22% ± 11%	Explore
lung	6 studies	28% ± 9%	Explore
brain	4 studies	19% ± 2%	Explore
pancreas	3 studies	28% ± 5%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
breast	100%	3648.30	459 / 459	100%	150.91	1118 / 1118
esophagus	100%	3836.37	1445 / 1445	100%	94.89	183 / 183
kidney	100%	3332.84	89 / 89	100%	114.09	901 / 901
liver	100%	3096.58	226 / 226	100%	106.24	406 / 406
lung	100%	3329.30	578 / 578	100%	123.09	1155 / 1155
ovary	100%	2519.84	180 / 180	100%	154.44	430 / 430
prostate	100%	3268.43	245 / 245	100%	130.70	502 / 502
skin	100%	4685.11	1809 / 1809	100%	138.62	472 / 472
stomach	100%	3383.45	359 / 359	100%	120.86	286 / 286
thymus	100%	3268.56	653 / 653	100%	128.34	605 / 605
uterus	100%	3101.05	170 / 170	100%	158.96	459 / 459
brain	100%	3032.19	2639 / 2642	100%	165.53	705 / 705
intestine	100%	4223.62	966 / 966	100%	138.03	526 / 527
pancreas	100%	1838.91	327 / 328	100%	136.70	178 / 178
bladder	100%	3595.81	21 / 21	100%	145.40	502 / 504
adrenal gland	100%	4153.82	258 / 258	100%	126.34	229 / 230
adipose	100%	3934.41	1204 / 1204	0%	0	0 / 0
blood vessel	100%	4084.03	1335 / 1335	0%	0	0 / 0
eye	0%	0	0 / 0	100%	91.15	80 / 80
lymph node	0%	0	0 / 0	100%	148.09	29 / 29
spleen	100%	4176.90	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	100%	146.92	45 / 45
ureter	0%	0	0 / 0	100%	114.14	1 / 1
heart	99%	1968.34	856 / 861	0%	0	0 / 0
muscle	99%	1821.52	796 / 803	0%	0	0 / 0
peripheral blood	96%	2958.57	896 / 929	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0

III. Associated gene sets

GO_0006915	Biological process	apoptotic process
GO_0008150	Biological process	biological_process
GO_0005730	Cellular component	nucleolus
GO_0005654	Cellular component	nucleoplasm
GO_0005515	Molecular function	protein binding
GO_0003723	Molecular function	RNA binding

IV. Literature review

[source]

Gene name	FAM32A
Protein name	Protein FAM32A Protein FAM32A (Ovarian tumor-associated gene 12) (OTAG-12)
Synonyms	CGI-144 OTAG12
Description	FUNCTION: Isoform 1, but not isoform 2 or isoform 3, may induce G2 arrest and apoptosis. May also increase cell sensitivity to apoptotic stimuli. .
Accessions	ENST00000263384.12 [Q9Y421-1] ENST00000588367.5 ENST00000585831.5 ENST00000587351.1 K7ELZ8 Q9Y421 K7ENN5 K7EIY1 ENST00000589852.5 [Q9Y421-3]

FAM32A report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review